Cargando…
COVID-19: is fibrosis the killer?
COVID-19 is a respiratory disease. A recent report in Lancet examined, retrospectively, 137 patients with COVD-19. Patients that died had elevated IL-6 levels and acute respiratory distress syndrome. These data have obvious implications for how to control mortality in COVID-19.
Autor principal: | Leask, Andrew |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7220615/ https://www.ncbi.nlm.nih.gov/pubmed/32406037 http://dx.doi.org/10.1007/s12079-020-00569-0 |
Ejemplares similares
-
Slow train coming: an anti-CCN2 strategy reverses a model of chronic overuse muscle fibrosis
por: Leask, Andrew
Publicado: (2020) -
The skinny on CCN2
por: Leask, Andrew
Publicado: (2008) -
Hijacking ZIP codes: posttanscriptional regulation of CCN2 by nucleophosmin
por: Leask, Andrew
Publicado: (2009) -
Trial by CCN2: a standardized test for fibroproliferative disease?
por: Leask, Andrew
Publicado: (2009) -
A sticky situation: CCN1 promotes both proliferation and apoptosis of cancer cells
por: Leask, Andrew
Publicado: (2009)